Stenotrophomonas maltophilia infections: Current status on first-line therapy and other treatment options

抗生素耐药性 生物 抗生素 嗜麦芽窄食单胞菌 流出 抗菌剂 抗药性 重症监护医学 病菌 多重耐药 联合疗法 医学 药物治疗 爆发 二氢蕨酸合酶 微生物学 临床试验 人类病原体 细菌遗传学 基因 甲氧苄啶 增强剂 生物信息学 功能(生物学) 后天抵抗 抗生素治疗 免疫学 药品 替加环素 计算生物学 抗感染药 机制(生物学)
作者
Nisanart Charoenlap,Suleepon Poomchuchit,Skorn Mongkolsuk,Paiboon Vattanaviboon
出处
期刊:Acta microbiologica et immunologica Hungarica (Print) [Akadémiai Kiadó]
卷期号:73 (2): 119-130 被引量:2
标识
DOI:10.1556/030.2026.02883
摘要

Stenotrophomonas maltophilia is an opportunistic pathogen primarily associated with hospital-acquired infections, particularly in individuals who are immunocompromised. S. maltophilia infections pose a significant clinical challenge due to the bacterium's sophisticated intrinsic and acquired mechanisms, which render it naturally multidrug resistant. The management of such infections is thus difficult, as the availability of effective therapeutic agents is limited. Antibiotic therapy options include co-trimoxazole, minocycline, tigecycline, levofloxacin, cefiderocol, and ceftazidime-avibactam. Co-trimoxazole, which comprises a synergistic combination of trimethoprim and sulfamethoxazole, remains the recommended first-line therapy for S. maltophilia infections. In this review, we critically evaluate the current evidence on the efficacy of co-trimoxazole against S. maltophilia. The present global prevalence of co-trimoxazole resistance in S. maltophilia clinical isolates varies from <5% to approximately 44%, raising concerns about its long-term reliability. Resistance to co-trimoxazole arises through several mechanisms. Horizontal gene transfer can introduce sul genes, which encode sulfonamide-insensitive dihydropteroate synthase, or dfrA genes, which encode trimethoprim-insensitive dihydrofolate reductase. Both enzymes function within the folate biosynthesis pathway, and their expression directly confers co-trimoxazole resistance. S. maltophilia can also acquire co-trimoxazole resistance through genetic mutations. The overexpression of efflux systems such as SmeVWX and SmeDEF, contributes to high-level resistance to co-trimoxazole, often triggered by mutations in the transcriptional regulators. Resistant strains frequently emerge due to improper antimicrobial use, as environmental antibiotic residues can act as selection pressure, facilitating the emergence and persistence of resistant strains. Despite these challenges, co-trimoxazole continues to demonstrate substantial clinical utility. It remains effective in many settings, either as monotherapy or in combination with other antibiotics such as minocycline, tigecycline, cefiderocol, or levofloxacin, and often achieves favorable outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
lh完成签到,获得积分10
1秒前
sendou的应助被文艺白曼采纳,获得20
2秒前
情怀的应助被奋斗的凌青采纳,获得30
2秒前
所所的应助被sqqx采纳,获得10
2秒前
云云完成签到,获得积分10
2秒前
2秒前
12345完成签到,获得积分10
2秒前
秋秋发布了新的文献求助20
2秒前
唐唐发布了新的文献求助10
2秒前
李元强完成签到,获得积分10
2秒前
猎人日记发布了新的文献求助10
3秒前
shiqian完成签到,获得积分20
3秒前
cookie发布了新的文献求助10
3秒前
小黄doge完成签到,获得积分10
3秒前
天天快乐的应助被王姿沣采纳,获得10
3秒前
科目三的应助被辣椒油采纳,获得10
4秒前
葛二蛋发布了新的文献求助10
4秒前
Hh完成签到,获得积分10
4秒前
4秒前
h7nho发布了新的文献求助10
5秒前
ZA完成签到,获得积分10
5秒前
5秒前
无情翅膀发布了新的文献求助10
5秒前
5秒前
斯文败类的应助被ypz采纳,获得10
6秒前
风趣的念薇完成签到,获得积分10
6秒前
xwf完成签到,获得积分10
6秒前
大巧若拙发布了新的文献求助20
7秒前
鱼儿发布了新的文献求助10
7秒前
苗条菠萝完成签到,获得积分10
8秒前
LHM发布了新的文献求助10
8秒前
Chambray发布了新的文献求助10
8秒前
9秒前
GChen7完成签到,获得积分10
9秒前
10秒前
zyu完成签到,获得积分10
10秒前
汤雄文完成签到,获得积分10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175556
求助须知:如何正确求助?哪些是违规求助? 9567240
关于积分的说明 21791502
捐赠科研通 7770174
什么是DOI,文献DOI怎么找? 3431868
关于科研通互助平台的介绍 2556244
邀请新用户注册赠送积分活动 2477299